Early identification and standardized diagnosis are essential for improving prognosis. Diagnosis of the disease requires a combination of clinical performance, imaging, laboratory testing and pathological activation. The platform can assist in linking teams of authoritative experts at home and abroad to provide accurate diagnosis and treatment programs.
Treatment and management of congenital heart defects require individualized management, typically including drug therapy, rehabilitation interventions, regular follow-up, and other multidimensional management. In recent years, with the development of therapeutic, immune-regulated therapy and precision medicine, many previously difficult-to-treat genetic metabolic disorders have been significantly improved. Treatment processes require close monitoring of therapeutic effects and adverse reactions, adapting timely to changes in disease.
Multidisciplinary collaboration (MDT) is particularly important for the comprehensive management of abnormalities associated with congenital carcinoma. 2. Visiting China: arranging face-to-face treatment with authoritative experts, developing individualized treatment programs; 3.
Full-service: providing one-stop services such as medical translation, medical care, accommodation arrangements; 4. Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of changes in conditions and treatment effects.